Fundraising FoxMeissa Vaccines
San Francisco, US · Founded 2014 · Delaware corporation · 1 known investors
Find your way into Meissa Vaccines
Sign up to see every warm intro you have to Meissa Vaccines
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Meissa Vaccines team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
Meissa Vaccines was founded in 2014 by Martin Moore and Roderick Tang.
Investors · 1
FundRxreportedPalo Alto
How we know: funding news · biospace.com · Not right? Tell us
Funding
SEC filings, press & company announcements$15.2M disclosed across 2 of 4 rounds · 2016–2019
▶$13.9MraisedOct 2019 · 37 investors · BiotechnologyRule 506(b)
▶$13.9MraisedOct 2019 · 37 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Martin MooreExecutive Officer, Director
- Kenneth KelleyDirector
- Stephanie O?BrienDirector
- William DalyDirector
- Isaac ChengDirector
- Roderick TangExecutive Officer
- Offering amount
- $33.9M
- Amount sold
- $13.9M
- First sale
- Sep 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.2MraisedOct 2017 · 14 investors · PharmaceuticalsRule 506(b)
▶$1.2MraisedOct 2017 · 14 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Martin MooreExecutive Officer, Director, Promoter
- Roderick TangExecutive Officer, Director, Promoter
- Offering amount
- $5M
- Amount sold
- $1.2M
- First sale
- Jul 2016
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 3 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2018 | $1.3M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2017 | $224.1K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2017 | $216.4K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- Who founded Meissa Vaccines?
- Meissa Vaccines was founded by Martin Moore, Roderick Tang in 2014.
- Who are Meissa Vaccines's investors?
- Meissa Vaccines's investors include FundRx.
- How much funding has Meissa Vaccines raised?
- Meissa Vaccines has disclosed $15.2M raised across 2 of its 4 known rounds.
- Where is Meissa Vaccines headquartered?
- Meissa Vaccines is headquartered in San Francisco, US.